2013 Fiscal Year Final Research Report
Omics-based analysis in malignant pheochromocytoma and paraganglioma.
| Project/Area Number |
23590666
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Laboratory medicine
|
|---|
| Research Institution | Hamamatsu University School of Medicine |
|---|
Principal Investigator |
IINO KAZUMI 浜松医科大学, 医学部附属病院, 助教 (90402263)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
MAEKAWA Masato 浜松医科大学, 医学部, 教授 (20190291)
OKI Yutaka 浜松医科大学, 医学部, 教授 (20169204)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Keywords | 褐色細胞腫 / パラガングリオーマ / メチル化解析 |
|---|
| Research Abstract |
We investigated methylation of malignant pheochromocytoma (PCC) and paraganglioma (PGL) tumors. We performed Infinium HumanMethylation450 Bead Chip array, which covers 485,577 CpG sites using DNA samples extracted from resected PCC/PGL tissues.
From the results of the Bead Chip array, we selected 12 CpG sites as hypermethylated and 16 CpG sites as hypomethylated candidates. Successively performed semiquantitative methylation-PCR revealed that, of the 28, three CpG sites were selected as possible epigenomic contributors to canceration of PCC/PGL. (one hypermethylated (cg02119938) and two hypomethylated sites (cg16918905, cg26870725). ) The cg02119938 is related to ACSBG1 (acyl-CoA synthetase bubblegum family member 1) gene, and cg26870725 is related to the MAST1 (microtubule associated serine-threonine kinase 1) gene. We showed here three possible CpG sites, in which aberrant promoter methylation/demethylation might be involved in silencing/expressing of cancer-related genes.
|
